The Pennsylvania Supreme Court ruled in the most recent (redux) fen phen lawsuit that the maker of the weight-loss diet drug fen phen, redux etc. that took off and went bust in the diet drug craze must face claims that its warning labels were inadequate.
The latest Fen phen lawsuit is against Delaware-based Wyeth, formerly known as American Home Products.
The Pennsylvania Supreme Court recently reinstated the fen phen lawsuit claims that the company negligently designed and marketed a diet pill, Redux, (fen phen) that’s now withdrawn from the market.
A judge in Philadelphia had previously dismissed the redux fen phen lawsuit after finding that a seller cannot be held liable without proof of an impurity or an inadequacy in labeling. The defendant now has to defend the redux fen phen lawsuit based on alleged claims that its product – redux (fen phen) – caused the woman who took it died from complications of primary pulmonary hypertension.
The fen phen lawsuit (lance v wyeth_pennsylvania_2014) alleged:
- The case was commenced against Wyeth and affiliated entities in the fall of 2006
- Appellee alleged that her daughter, Catherine Lance, ingested Redux for several months in 1997
- the drug caused PPH, from which she died within a month after her diagnosis in 2004
Fen Phen may be linked to Primary Pulmonary Hypertension (PPH) or Primary Arterial Hypertension (PAH) or Idiopathic Primary Arterial Hypertension (IPAH) (hereinafter “PPH”, “IPAH” or “PAH”) is an increase in blood pressure in the lung vasculature which comprises the pulmonary artery, pulmonary vein or pulmonary capillaries. It is a rare lung disorder in which the blood pressure in the pulmonary artery rises far above normal levels for no apparent reason. PPH or PAH can be one of five different types:
In addition, fen phen has been linked to heart valve damage too. Unfortunately, an estimated 500 to 1,000 new cases of Primary Pulmonary Hypertension (PPH) or Primary Arterial Hypertension (PAH) are diagnosed each year, and many doctors and experts believe that Primary Pulmonary Hypertension (PPH) or Primary Arterial Hypertension (PAH) is linked to the diet drug Fen-Phen.
For more information on FEN PHEN, click here.
At the Gooch Law Firm, we pride ourselves on providing our clients reliable representation for even the most challenging cases. If you took Fen-Phen and have been diagnosed with one of the above problems, please contact our office at 1.844.329.5955.
WE ARE HERE TO HELP YOU PROTECT YOUR LEGAL RIGHTS